Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

India Invites Consumers To File Complaints Of Drug-Price Violations

This article was originally published in PharmAsia News

Executive Summary

An Indian ministry has taken steps to ease the process for consumers to file complaints against drug makers for violating price caps. The new initiative of the Chemicals and Fertilisers Ministry would allow consumers to file complaints with the National Pharmaceutical Pricing Authority on its Web site, with the NPPA to respond within 30 days. Consumers who file legitimate complaints would be rewarded with about $25 per complaint. The Web site also was expected to enhance consumer awareness about the price of drugs. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC068050

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel